MLN-2480

Products

ace

Inquiry

ace

* First Name
* Last Name
* Business Email
Phone
Company/Institution
Job Title
* Services or Products of Interest (DIA-0230549) MLN-2480
When do you expect your project to start?
Project Description
* All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
* Tick to confirm the Research Use Only (RUO) statement.

MLN-2480

Inquiry

Cat. No.: DIA-0230549

Size: 50 mg Size: 500 mg Size: Customer Size

Product Information
CAS No.	1096708-71-2
Synonyms	BIIB-024, TAK580
Formula	C₁₇H₁₂Cl₂F₃N₇O₂S
Molecular Weight	506.29
SMILES	CC(NC(=O)C1=C(Cl)C(=NC=N1)N)C2=NC=C(S2)C(=O)NC3=NC=C(Cl)C(=C3)C(F)(F)F
Product Description	MLN2480 is an oral, selective pan-Raf kinase inhibitor in chinical trials.

Format & Storage
Purity	> 98%
Shipping	Shipped on dry ice.
Storage	Powder: -20 °C, 3 years; 4 °C, 2 years In solvent: -80 °C, 6 months; -20 °C, 1 month
Solubility Overview	Soluble in DMSO

All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links

Contact Info

Copyright © Ace Therapeutics. All Rights Reserved.

Top